← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,142 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
AP
AMPCO PITTSBURGH CORP
Fairly valued
Industrials
Price$9.25
Model IV$9.52
P/IV0.95
Discount 3% Return to IV: +2.9%
Market implies +2.8%/yr vs model +5.9% · below model
APAC
StoneBridge Acquisition II Corp
Valuation N/A
Financial Services
Price$10.27
Model IV—
P/IV—
Limited data — see page
APACR
StoneBridge Acquisition II Corp
Valuation N/A
Financial Services
Price$0.11
Model IV—
P/IV—
Limited data — see page
APACU
StoneBridge Acquisition II Corp
Valuation N/A
Financial Services
Price$10.45
Model IV—
P/IV—
Limited data — see page
APC
ARKO Petroleum Corp.
Valuation N/A
Consumer Defensive
Price$16.15
Model IV—
P/IV—
Limited data — see page
APLM
Apollomics Inc.
Valuation N/A
Healthcare
Price$21.50
Model IV—
P/IV—
Limited data — see page
APLMW
Apollomics Inc.
Valuation N/A
Healthcare
Price$0.01
Model IV—
P/IV—
Limited data — see page
APM
APM
Valuation N/A
Price$8.41
Model IV—
P/IV—
Limited data — see page
APRE
Aprea Therapeutics, Inc.
Valuation N/A
Healthcare
Price$0.60
Model IV—
P/IV—
Limited data — see page
APT
ALPHA PRO TECH LTD
Deeply overvalued
Healthcare
Price$5.84
Model IV$4.31
P/IV1.21
Premium +36% Return to IV: -26.2%
Market implies +6.9%/yr vs model +5.9% · in line
APUS
Apimeds Pharmaceuticals US, Inc.
Valuation N/A
Healthcare
Price$5.02
Model IV—
P/IV—
Limited data — see page
APVO
Aptevo Therapeutics Inc.
Valuation N/A
Healthcare
Price$1.79
Model IV—
P/IV—
Market implies -21.7%/yr
APWC
ASIA PACIFIC WIRE & CABLE CORP LTD
Deeply overvalued
Basic Materials
Price$1.38
Model IV$0.54
P/IV2.47
Premium +158% Return to IV: -61.2%
Market implies +16.2%/yr vs model +6.7% · above model
APXT
Apex Treasury Corp
Valuation N/A
Financial Services
Price$10.16
Model IV—
P/IV—
Limited data — see page
APXTU
Apex Treasury Corp
Valuation N/A
Financial Services
Price$10.27
Model IV—
P/IV—
Limited data — see page
APXTW
Apex Treasury Corp
Valuation N/A
Financial Services
Price$0.28
Model IV—
P/IV—
Limited data — see page
APYX
Apyx Medical Corp
Valuation N/A
Healthcare
Price$2.59
Model IV—
P/IV—
Market implies +19.3%/yr
AQB
AQUABOUNTY TECHNOLOGIES INC
Valuation N/A
Basic Materials
Price$1.05
Model IV—
P/IV—
Market implies +39.8%/yr vs model +5.0% · above model
AQMS
Aqua Metals, Inc.
Valuation N/A
Basic Materials
Price$2.03
Model IV—
P/IV—
Market implies +51.0%/yr vs model +5.0% · above model
ARAI
Arrive AI Inc.
Valuation N/A
Technology
Price$0.15
Model IV—
P/IV—
Market implies +41.7%/yr
ARAY
ACCURAY INC
Valuation N/A
Healthcare
Price$0.23
Model IV—
P/IV—
Market implies -37.5%/yr vs model +2.0% · below model
ARBB
ARB IOT Group Ltd
Deeply overvalued
Technology
Price$4.37
Model IV$1.15
P/IV3.97
Premium +281% Return to IV: -73.7%
Market implies +25.2%/yr vs model +12.0% · above model
ARBE
Arbe Robotics Ltd.
Valuation N/A
Technology
Price$0.55
Model IV—
P/IV—
Market implies +47.0%/yr
ARBEW
Arbe Robotics Ltd.
Valuation N/A
Technology
Price$0.02
Model IV—
P/IV—
Market implies +15.0%/yr vs model +2.0% · above model
ARBK
Argo Blockchain Plc
Valuation N/A
Financial Services
Price$2.10
Model IV—
P/IV—
Market implies +66.6%/yr
ARCIW
Archimedes Tech SPAC Partners III Co.
Valuation N/A
Financial Services
Price$0.40
Model IV—
P/IV—
Limited data — see page
ARCL
ARC Group Acquisition I Corp.
Valuation N/A
Financial Services
Price$10.00
Model IV—
P/IV—
Limited data — see page
ARCLU
ARC Group Acquisition I Corp.
Valuation N/A
Financial Services
Price$10.17
Model IV—
P/IV—
Limited data — see page
ARDC
Ares Dynamic Credit Allocation Fund, Inc.
Valuation N/A
Unknown
Price$11.45
Model IV—
P/IV—
Limited data — see page
AREC
American Resources Corp
Valuation N/A
Energy
Price$1.59
Model IV—
P/IV—
Market implies +50.0%/yr vs model +4.0% · above model
AREN
AREN
Valuation N/A
Price$1.03
Model IV—
P/IV—
Limited data — see page
ARKR
ARK RESTAURANTS CORP
Deeply undervalued
Consumer Cyclical
Price$4.47
Model IV$23.88
P/IV0.19
Discount 81% Return to IV: +434.6%
Market implies -35.0%/yr vs model +5.9% · below model
ARL
AMERICAN REALTY INVESTORS INC
Deeply overvalued
Real Estate
Price$16.45
Model IV$4.90
P/IV3.31
Premium +236% Return to IV: -70.2%
ARMP
Armata Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$3.63
Model IV—
P/IV—
Limited data — see page
ARQ
Arq, Inc.
Valuation N/A
Basic Materials
Price$2.03
Model IV—
P/IV—
Market implies +47.9%/yr vs model +4.9% · above model
ARQQW
Arqit Quantum Inc.
Valuation N/A
Technology
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
ARRT
Artisan Consumer Goods, Inc.
Deeply overvalued
Basic Materials
Price$0.32
Model IV$0.10
P/IV3.54
Premium +229% Return to IV: -69.6%
Market implies +16.4%/yr vs model +5.0% · above model
ARTC
Art Technology Acquisition Corp.
Valuation N/A
Financial Services
Price$9.99
Model IV—
P/IV—
Limited data — see page
ARTCU
Art Technology Acquisition Corp.
Valuation N/A
Financial Services
Price$10.15
Model IV—
P/IV—
Limited data — see page
ARTCW
Art Technology Acquisition Corp.
Valuation N/A
Financial Services
Price$0.28
Model IV—
P/IV—
Limited data — see page
ARTL
ARTELO BIOSCIENCES, INC.
Valuation N/A
Healthcare
Price$3.26
Model IV—
P/IV—
Limited data — see page
ARTW
ARTS WAY MANUFACTURING CO INC
Deeply overvalued
Industrials
Price$3.54
Model IV$1.06
P/IV2.95
Premium +235% Return to IV: -70.1%
Market implies +17.6%/yr vs model +2.0% · above model
ASBP
Aspire Biopharma Holdings, Inc.
Valuation N/A
Healthcare
Price$8.30
Model IV—
P/IV—
Market implies +116.2%/yr
ASBPW
Aspire Biopharma Holdings, Inc.
Deeply overvalued
Healthcare
Price$0.01
Model IV$0.01
P/IV2.64
Premium +77% Return to IV: -43.6%
Market implies +0.0%/yr vs model +15.0% · below model
ASG
LIBERTY ALL STAR GROWTH FUND INC.
Valuation N/A
Unknown
Price$5.08
Model IV—
P/IV—
Limited data — see page
ASLE
AerSale Corp
Valuation N/A
Industrials
Price$5.08
Model IV—
P/IV—
Market implies +54.5%/yr
ASPC
ASPAC III Acquisition Corp.
Valuation N/A
Financial Services
Price$10.77
Model IV—
P/IV—
Limited data — see page
ASPCR
ASPAC III Acquisition Corp.
Valuation N/A
Financial Services
Price$0.08
Model IV—
P/IV—
Limited data — see page
ASPCU
ASPAC III Acquisition Corp.
Valuation N/A
Financial Services
Price$11.99
Model IV—
P/IV—
Limited data — see page
ASPS
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
Deeply undervalued
Technology
Price$5.99
Model IV$30.74
P/IV0.21
Discount 81% Return to IV: +413.3%
Market implies -34.9%/yr vs model +2.0% · below model
ASPSZ
ALTISOURCE PORTFOLIO SOLUTIONS S.A.
Valuation N/A
Technology
Price$0.15
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
ASRT
ASRT
Valuation N/A
Price$23.50
Model IV—
P/IV—
Limited data — see page
ASRV
AMERISERV FINANCIAL INC /PA/
Fairly valued
Financial Services
Price$4.39
Model IV$4.05
P/IV1.10
Premium +9% Return to IV: -7.8%
ASST
Strive, Inc.
Valuation N/A
Financial Services
Price$27.80
Model IV—
P/IV—
Market implies +30.4%/yr
ASTC
ASTROTECH Corp
Valuation N/A
Healthcare
Price$6.81
Model IV—
P/IV—
Market implies +41.4%/yr
ASTI
Ascent Solar Technologies, Inc.
Valuation N/A
Technology
Price$2.19
Model IV—
P/IV—
Market implies +79.6%/yr
ASTLW
Algoma Steel Group Inc.
Deeply undervalued
Basic Materials
Price$0.00
Model IV$0.08
P/IV0.13
Discount 98% Return to IV: +4,066.7%
Market implies -50.0%/yr vs model +5.0% · below model
ASUR
ASURE SOFTWARE INC
Undervalued
Technology
Price$7.34
Model IV$9.78
P/IV0.79
Discount 25% Return to IV: +33.3%
Market implies +6.1%/yr vs model +15.9% · below model
ATCH
AtlasClear Holdings, Inc.
Valuation N/A
Financial Services
Price$0.18
Model IV—
P/IV—
Market implies +21.9%/yr
ATCX
ATLAS CRITICAL MINERALS Corp
Valuation N/A
Basic Materials
Price$2.60
Model IV—
P/IV—
Market implies +54.3%/yr vs model +5.0% · above model